Non-marketable Equity Securities	3 Months Ended
Non-marketable Equity Securities	Mar. 31, 2012
Investments, All Other Investments [Abstract]
Non-marketable Equity Securities	Non-marketable Equity Securities The aggregate cost of the Company's cost method investments totaled $8,860,953 at March 31, 2012 and $8,771,278 at December 31, 2010. Cost method investments at March 31, 2012 include $6,130,000 in FHLB stock and $2,730,953 of investments in various trust and financial companies, which are included in other assets. All cost method investments were evaluated for impairment at March 31, 2012 and December 31, 2011. The following factors have been considered in determining the carrying amount of FHLB stock: 1) the recoverability of the par value, 2) the Company has sufficient liquidity to meet all operational needs in the foreseeable future and would not need to dispose of the stock below recorded amounts, 3) redemptions and purchases of the stock are at the discretion of the FHLB, 4) the Company believes the FHLB has the ability to absorb economic losses given the expectation that the various FHLBs' have a high degree of government support, and 5) the unrealized losses related to securities owned by the FHLB are manageable given the capital levels of the organization. The Company estimated that the fair value equaled or exceeded the cost of these investments (that is, the investments were not impaired) as of March 31, 2012. During the first quarter of 2011, the Company's investment in a financial services company and a local community bank were considered to be other than temporarily impaired and approximately $20,000 was charged-off. In addition to the impairment charges recorded for the quarter ended March 31, 2011, the Company sold one of its investments in a financial services company for a loss of $79,910.

The entire disclosure for investments accounted for under the cost-method. The carrying amount of such investments may be adjusted, for example, distributions in excess of cost (return of capital) or for other-than-temporary impairments. The cost method and lower-of-cost or market, an adaptation of the cost method, is generally followed for most investments in noncontrolled corporations, in some corporate joint ventures, and to a lesser extent in unconsolidated subsidiaries in which the entity does not have the ability to exercise significant influence.

+ References+ Details